Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma (Q35551020)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma |
scientific article published on October 1, 2003 |
Statements
1 reference
Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma (English)
1 reference
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma (English)
Patricia Brophy
1 reference
Mark Hickeson
1 reference
Sydney Heyman
1 reference
Martin Charron
1 reference
Tammy I. Kang
Audrey E. Evans
1 October 2003
1 reference
1 reference
Identifiers
1 reference